SGLT2 inhibitors

Diabetes drugs cut Alzheimer's risk

Diabetes drugs cut Alzheimer’s risk by nearly half

A comprehensive analysis reveals that specific diabetes treatments could significantly reduce dementia risk, potentially transforming prevention strategies for millions. The connection between metabolic health and

diabetes drug for heart health

The breakthrough medication reshaping diabetes care

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope for

diabetes drug for heart health

Breakthrough diabetes drug slashes dementia risk by 35%

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications offer